GenMark Diagnostics, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. GNMK has around 5.1M shares in the U.S. ETF market. The largest ETF holder of GNMK is the iShares Russell 2000 ETF (IWM), with approximately 1.52M shares. Investors may also find of interest that the ETF with the largest allocation to GNMK stock is SPDR S&P Health Care Equipment ETF (XHE), with a portfolio weight of 1.35%. On average, U.S. ETFs allocate 0.13% of GNMK to their portfolios.
Additionally, GNMK is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with GNMK as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 45.35%.